MedPath

transcranial magnetic stimulation as a treatment modality in migraine headache

Phase 3
Completed
Conditions
Health Condition 1: null- patients suffering from migraine
Registration Number
CTRI/2018/05/013596
Lead Sponsor
Central Institute of Psychiatry Ranchi University Ranchi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
56
Inclusion Criteria

1.Diagnosis of simple migraine with or without tension type headache according to International Headache society Classification, ICHD-II. (Society H.C.S., 2004)

2.Subjects of either sex aged between 18-60 years.

3.Right handed subjects.

4.Migraine patients with at least 2 migraine attacks per month for last three months.

5.Patients taking prophylactic medication for migraine to continue the medication during study.

6.Subjects giving written informed consent.

Exclusion Criteria

1.Any other type of chronic or recurrent headache.

2.Other Neurological or major psychiatric disease.

3.Other physical conditions like active infectious diseases, connective tissue diseases, other clinically relevant painful conditions including recent injuries, malignancy, previous craniotomy or cervical spine surgery, heart disease, cardiopulmonary diseases, pregnancy.

4.Having any cochlear implants, cardiac pacemaker, metal body implanted in head neck region.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. reduction in the frequency, duration and severity of migraine pain and reduction of the migraine disability in patients receiving active stimulation in comparison to sham group. <br/ ><br>2.There was reduced sensory gating of auditory responses in migraine patients in comparison to healthy controls. <br/ ><br>3.Interictally in migraine patients the process of sensory gating differed at different brain regions with respect to time <br/ ><br>Timepoint: After 2 weeks, 4 weeks, 6 weeks and 12 weeks of rtms treatment <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
iTBS had no effect in altering the P50 sensory gating in migraine patientsTimepoint: baseline and after 10 session of rtms
© Copyright 2025. All Rights Reserved by MedPath